How ICH E6(R3) is set to upgrade clinical trials: Insights from industry experts
The E6(R3) Guideline for Good Clinical Practice revises ICH E6(R2) and is expected to go live in 2025. To understand the potential impacts of this guideline on clinical research, Outsourcing-Pharma spoke with TransCelerate BioPharma Inc. member Madeleine …